KR20220133454A - A composition comprising fermented Stichopus japonicus extract and fermented Black ginseng extract for improvement of immunity - Google Patents

A composition comprising fermented Stichopus japonicus extract and fermented Black ginseng extract for improvement of immunity Download PDF

Info

Publication number
KR20220133454A
KR20220133454A KR1020210038564A KR20210038564A KR20220133454A KR 20220133454 A KR20220133454 A KR 20220133454A KR 1020210038564 A KR1020210038564 A KR 1020210038564A KR 20210038564 A KR20210038564 A KR 20210038564A KR 20220133454 A KR20220133454 A KR 20220133454A
Authority
KR
South Korea
Prior art keywords
fermented
sea cucumber
black ginseng
extract
ginseng
Prior art date
Application number
KR1020210038564A
Other languages
Korean (ko)
Other versions
KR102643524B1 (en
Inventor
손미례
이한준
민원경
신현호
Original Assignee
(주) 아이투디
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주) 아이투디 filed Critical (주) 아이투디
Priority to KR1020210038564A priority Critical patent/KR102643524B1/en
Publication of KR20220133454A publication Critical patent/KR20220133454A/en
Application granted granted Critical
Publication of KR102643524B1 publication Critical patent/KR102643524B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L17/00Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
    • A23L17/40Shell-fish
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/616Echinodermata, e.g. starfish, sea cucumbers or sea urchins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258Panax (ginseng)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/20Natural extracts
    • A23V2250/21Plant extracts
    • A23V2250/2124Ginseng
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10Preparation or pretreatment of starting material
    • A61K2236/19Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Immunology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to an immunity enhancing composition containing a fermented sea cucumber extract and a fermented black ginseng extract as active ingredients. The composition of the present invention increases cytokine (TNF-α, IL-6, IL-1β) secretion ability and nitric oxide secretion ability without increasing reactive oxygen species and induces phosphorylation of MAPKs, expression of NF-κB, and expression of cell surface activators.

Description

발효해삼 추출물 및 발효흑삼 추출물을 유효성분으로 함유하는 면역력 증진 조성물{A composition comprising fermented Stichopus japonicus extract and fermented Black ginseng extract for improvement of immunity}Immunity enhancement composition comprising fermented sea cucumber extract and fermented black ginseng extract as active ingredients {A composition comprising fermented Stichopus japonicus extract and fermented Black ginseng extract for improvement of immunity}

본 발명은 발효해삼 추출물 및 발효흑삼 추출물을 유효성분으로 함유하는 면역력 증진 조성물에 관한 것이다. The present invention relates to an immunity enhancing composition comprising a fermented sea cucumber extract and a fermented black ginseng extract as active ingredients.

본 발명은 다음과 같은 연구과제를 통해 도출된 결과물이다.The present invention is a result derived through the following research project.

[부처명 : 충청남도 서천군 / 과제관리전문기관명 : 충남테크노파크 [Name of department: Seocheon-gun, Chungcheongnam-do / Name of task management agency: Chungnam Technopark

연구사업명 : 2020년 해양바이오 전략소재 및 상품화 공정개발 지원사업Research project name: 2020 marine bio strategic material and commercialization process development support project

연구과제명 : 다당체 성분이 증진된 해삼복합소재(SJBG-F)를 이용한 면역조절능 증진 소재제조, 응용제품 개발 및 산업화Research project name: Manufacture of materials for enhancing immune regulation using sea cucumber complex (SJBG-F) with enhanced polysaccharide components, development and industrialization of applied products

연구기간 : 2020.5.11~2021.4.10]Research period: 2020.5.11~2021.4.10]

인삼의 주요 생리활성 물질들은 진세노사이드(ginsenoside)와, 폴리아세틸렌(polyacetylene), 다당체(polysaccharide), 인삼 단백질 및 페놀성 물질 등이 알려져 왔다. The major physiologically active substances of ginseng have been known, such as ginsenoside, polyacetylene, polysaccharide, ginseng protein, and phenolic substances.

진세노사이드는 면역 및 염증 반응 조절에 관여한다고 알려져 있다. 또한 다당체들은 면역조절(immunostimulatory), 항암(antitumor), 항산화(antioxidant)등의 효능이 있는 것으로 발표되고 있다. Ginsenosides are known to be involved in the regulation of immune and inflammatory responses. In addition, polysaccharides have been reported to have effects such as immunostimulatory, antitumor, and antioxidant.

해삼(Stichopus japonicus)은 ‘바다의 인삼’이란 뜻으로 실제로 해삼에는 사포닌 성분이 포함되어 있으며, 해삼의 사포닌 성분이 고지방 사료로 유도된 마우스에서 비만 및 간 지방증과 glucose 과민증에 효과가 있다는 보고도 있다. Sea cucumber (Stichopus japonicus) means 'ginseng of the sea'. Sea cucumber actually contains saponins, and there are reports that the saponins of sea cucumber are effective in obesity, hepatic steatosis, and glucose hypersensitivity in mice induced with a high-fat diet. .

해삼의 일반 성분은 단백질 함량이 2~5%이며 지방은 0~0.4%로 그 함량이 매우 낮으며, 미네랄은 칼슘과 나트륨이 굴, 가리비 등에 비해 10배 이상 많으며, 칼륨, 아연, 구리, 철분은 미량 함유하고 있으며 동물 등의 세포간 조직, 신경조직 및 연골조직에서 발견되는 당단백질인 황산 콘드로이친 (Chondroitin sulfate, Chs)을 2.6~3.2%를 함유하고 있다. The general component of sea cucumber has a protein content of 2-5% and fat is 0-0.4%, which is very low. As for minerals, calcium and sodium are 10 times more than oysters and scallops, and potassium, zinc, copper, iron It contains 2.6~3.2% of chondroitin sulfate (Chs), a glycoprotein found in intercellular tissues, nerve tissues and cartilage tissues such as animals.

해삼의 기능성에 관한 연구로 해삼의 사포닌 성분은 고지방식이를 먹인 mice에서 비만과 간지방증에 대한 보호 효과가 보고되었고, 해삼 당단백질과 황산콘드로이친은 항돌연변이 유발 실험과 사람의 위암세포와 결장암세포의 성장을 82~95%까지 크게 억제하는 것으로 알려져 있으며, 해삼에서 추출한 frondanol-A5는 췌장암 세포의 cell cycle arrest와 apoptosis를 일으켜 성장을 억제한다는 보고 등이 있다. 우리나라에서는 해삼을 오래 전부터 식용하고 있으나 그 이용성 등에 관한 연구는 많이 이루어지고 있지 않다. As a study on the functionality of sea cucumber, the protective effect of sea cucumber saponin against obesity and hepatic steatosis in mice fed a high-fat diet was reported. It is known that it significantly inhibits the growth of pancreatic cancer by 82~95%, and there are reports that frondanol-A5 extracted from sea cucumber inhibits growth by causing cell cycle arrest and apoptosis of pancreatic cancer cells. Sea cucumber has been eaten for a long time in Korea, but studies on its usefulness have not been conducted much.

따라서 본 출원인은 산성다당체의 기능성을 이용한 식품으로 해삼과 흑삼을 이용한 면역관련건강 식품을 개발하기 위해 해삼과 흑삼을 백국균(white-koji mould)으로 발효시켜 그 생리활성의 변화를 실험하여 본 발명을 완성하였다.Therefore, the present applicant fermented sea cucumber and black ginseng with white-koji mold to develop immune-related health food using sea cucumber and black ginseng as a food using the functionalities of acidic polysaccharide, and tested the change in physiological activity of the present invention. was completed.

선행기술문헌을 보면, 대한민국 등록특허공보 10-1712565에 '증숙건해삼의 제조방법 및 상기 증숙건해삼을 사용한 해삼성분이 함유된 건강식품 제조방법'이 기재되어 있고, 대한민국 공개특허공보 10-2013-0081009에 '건해삼 혼합 홍삼환의 제조방법 및 그 제조방법에 따라 제조된 건해삼 혼합 홍삼'이 기재되어 있으며, 대한민국 등록특허공보 10-1708167에 '홍삼과 해삼의 가수분해 원료를 포함한 식품조성물 및 그 제조방법'이 기재되어 있다. 그러나 상기 문헌들은 발효흑삼과 발효해삼에 대해서 기재되어 있지 않다. Looking at the prior art literature, Korean Patent Publication No. 10-1712565 describes 'a method for manufacturing steamed and dried sea cucumber and a method for manufacturing a health food containing sea cucumber component using the steamed and dried sea cucumber', and Korean Patent Publication No. 10-2013-0081009 'Method for manufacturing dried sea ginseng mixed red ginseng pills and dried sea ginseng mixed red ginseng manufactured according to the manufacturing method' is described in Korean Patent Publication No. 10-1708167, 'Food composition including hydrolyzed raw materials of red ginseng and sea cucumber and manufacturing method thereof' This is described. However, these documents do not describe fermented black ginseng and fermented sea cucumber.

대한민국 등록특허공보 10-1712565 (2017.02.27 등록)Republic of Korea Patent Publication No. 10-1712565 (registered on February 27, 2017) 대한민국 공개특허공보 10-2013-0081009 (2013.07.16 공개)Korean Patent Publication No. 10-2013-0081009 (published on July 16, 2013) 대한민국 등록특허공보 10-1708167 (2017.02.14 등록)Republic of Korea Patent Publication No. 10-1708167 (Registered on Feb. 14, 2017)

해결과제는, 발효해삼 추출물 및 발효흑삼 추출물을 유효성분으로 함유하는 면역력 증진 조성물을 제공하는 것이다. An object to be solved is to provide an immunity enhancing composition containing a fermented sea cucumber extract and a fermented black ginseng extract as an active ingredient.

해결수단은, 발효해삼 추출물 또는 발효흑삼 추출물 중 1 종 이상을 유효성분으로 함유하는 면역력 증진 조성물이다.The solution is an immunity enhancing composition containing at least one of a fermented sea cucumber extract or a fermented black ginseng extract as an active ingredient.

상기에서, 발효 균주는 백국균인 것을 특징으로 한다.In the above, the fermented strain is characterized in that the white chrysanthemum.

상기에서, 발효해삼이 이용되는 경우, 발효해삼은 건조해삼에 대하여 백국균을 1% 첨가하여 60시간 발효한 것을 특징으로 한다.In the above, when the fermented sea cucumber is used, the fermented sea cucumber is characterized in that it is fermented for 60 hours by adding 1% of white porcini bacteria to the dried sea cucumber.

상기에서, 발효해삼 추출물 및 발효흑삼 추출물이 혼합될 경우, In the above, when the fermented sea cucumber extract and the fermented black ginseng extract are mixed,

발효해삼 추출물과 발효흑삼 추출물은 3:7 중량비로 혼합되는 것을 특징으로 한다.It is characterized in that the fermented sea cucumber extract and the fermented black ginseng extract are mixed in a weight ratio of 3:7.

상기 조성물은,The composition is

활성산소종을 증가시키지 않고, 사이토카인(TNF-α, IL-6 , IL-1β) 분비능과 산화질소 분비능을 향상시키고, MAPKs의 인산화 및 NF-κB의 발현과 세포 표면 활성 인자 발현을 유도하는 것을 특징으로 한다.Without increasing reactive oxygen species, cytokine (TNF-α, IL-6, IL-1β) secretion and nitric oxide secretion, MAPKs phosphorylation, NF-κB expression, and cell surface activator expression induction characterized in that

본 발명에 따른 조성물은, 흑삼을 발효시킴으로써 21-25%로 산성다당체가 증가되고, 흑삼 특유의 진세노사이드인 Rg3, Rg5, Rk1 함량이 증가된 발효흑삼을 이용함으로써 그에 따른 효과를 보유하고 있다.The composition according to the present invention has the effect thereof by using fermented black ginseng with an increased acidic polysaccharide content of 21-25% by fermenting black ginseng, and Rg3, Rg5, and Rk1, which are ginsenosides characteristic of black ginseng. .

또한, 해삼을 발효시킴으로써 균 접종량과 발효시간에 따라 26.14-74.21%로 산성다당체가 증가된 발효해삼을 이용함으로써 그에 따른 효과를 보유하고 있다.In addition, by fermenting the sea cucumber, it has the corresponding effect by using the fermented sea cucumber with the acidic polysaccharide increased to 26.14-74.21% depending on the bacterial inoculation amount and fermentation time.

또한, 활성산소종을 증가시키지 않고, 사이토카인(TNF-α, IL-6 , IL-1β) 분비능을 향상시키며, 산화질소 분비능을 향상시키고, MAPKs의 인산화 및 NF-κB의 발현을 유도하며, 세포 표면 활성 인자 발현을 유도함으로써, 면역활성을 증진시키는 현저한 효과를 보유하고 있다.In addition, without increasing reactive oxygen species, it improves cytokine (TNF-α, IL-6, IL-1β) secretion ability, improves nitric oxide secretion, induces phosphorylation of MAPKs and expression of NF-κB, By inducing the expression of cell surface activator, it has a remarkable effect of enhancing immune activity.

도 1은 발효흑삼 추출물의 산성다당체 함량 분석 결과 그래프이다.
도 2는 발효해삼 추출물의 산성다당체 함량 분석 결과 그래프이다.
도 3은 발효흑삼 추출물의 진세노사이드 함량 변화 분석 결과 표이고, 도 4는 크로마토그램이다.
도 5는 세포생존율 분석 결과 그래프이다.
도 6은 세표사멸 분석 결과 그래프이다.
도 7은 활성산소종 평가 결과 그래프이다.
도 8은 사이토카인 분비능 분석 결과 그래프이다.
도 9는 산화질소 분비능 분석 결과 그래프이다.
도 10은 MAPKs 인산화 및 NF-κB 발현 분석 결과 그래프이다.
1 is a graph of the analysis result of acidic polysaccharide content of fermented black ginseng extract.
Figure 2 is a graph of the analysis result of the acid polysaccharide content of the fermented sea cucumber extract.
Figure 3 is a ginsenoside content change analysis result table of fermented black ginseng extract, Figure 4 is a chromatogram.
5 is a graph showing the results of cell viability analysis.
6 is a graph showing apoptosis analysis results.
7 is a graph showing the evaluation result of reactive oxygen species.
8 is a graph showing the results of cytokine secretion analysis.
9 is a graph showing the results of analysis of nitric oxide secretion.
10 is a graph showing the results of MAPKs phosphorylation and NF-κB expression analysis.

본 명세서 및 청구범위에 사용된 용어나 단어는 "발명자는 그 자신의 발명을 가장 최선의 방법으로 설명하기 위해 용어의 개념을 적절하게 정의할 수 있다는 원칙"에 입각하여 본 발명의 기술적 사상에 부합하는 의미와 개념으로 해석되어야지, 통상적이거나 사전적인 의미로 한정해서 해석되서는 안 된다.The terms or words used in the present specification and claims conform to the technical idea of the present invention based on the "principle that the inventor can appropriately define the concept of a term in order to best describe his invention" It should be interpreted as the meaning and concept that

따라서 본 명세서에 기재된 실시예와 도면에 도시된 구성은 본 발명의 가장 바람직한 실시예에 불과할 뿐이고, 본 발명의 기술적 사상을 모두 대변하는 것은 아니므로, 본 출원시점에 있어서 이들을 대체할 수 있는 다양한 균등물과 변형 예들이 있을 수 있음을 이해해야 한다.Therefore, the embodiments described in this specification and the configurations shown in the drawings are only the most preferred embodiments of the present invention, and do not represent all of the technical spirit of the present invention, so various equivalents that can replace them at the time of the present application It should be understood that there may be water and variations.

실험예 1. 재료 및 방법Experimental Example 1. Materials and Methods

1. 발효흑삼 제조1. Manufacture of fermented black ginseng

충남 금산 금산수삼시장에서 금산에서 재배된 5년근 인삼(Panax ginseng C. A. Meyer)을 구입하여 사용하였다. 인삼을 스크류 세척기 (Cleaning Machines, Sambo, Pocheon, Korea)에 넣고 10분간 총 3회 반복해서 세척하였으며 세척 과정 중에 껍질이 손상되지 않도록 세척하였다. 세척한 후 무게, 수분함량, 총당 및 조단백질 등을 분석 한 후, 평균 규격에 맞는 인삼을 선별한 후 흑삼의 가공 원료삼으로 사용하였다. Five-year-old ginseng (Panax ginseng C. A. Meyer) grown in Geumsan was purchased and used at the Geumsan Fresh Ginseng Market in Geumsan, Chungcheongnam-do. Ginseng was placed in a screw washing machine (Cleaning Machines, Sambo, Pocheon, Korea) and washed three times for 10 minutes in total, and washed so as not to damage the skin during the washing process. After washing, weight, moisture content, total sugar, and crude protein were analyzed, and ginseng meeting the average standard was selected and used as raw material for processing black ginseng.

세척된 인삼은 건조기 (KL-290, WooSung Election Company,Andong, Korea)를 이용하여 50℃에서 24시간 건조하여 표면이 건조된 삼을 제조하였으며 건조삼은 증숙기 (Mach Steamer 10-KM, Daechang ENG, Eumseong, Korea)를 사용하여 95℃에 서 6시간 증숙 후, 60℃에서 수분 함량 15%까지 건조하였다. Washed ginseng was dried at 50°C for 24 hours using a dryer (KL-290, WooSung Election Company, Andong, Korea) to prepare ginseng with the surface dried. Eumseong, Korea) was used for steaming at 95°C for 6 hours, and then dried at 60°C to a moisture content of 15%.

건조된 삼에 수분과 백국균(Aspergillus awamori var.kawachii : white-koji mould)을 접종하여 발효삼을 제조하였으며 다시 증숙 및 건조 과정을 5회 반복하여 최종적으로 수분함량이 13% - 15% 이내가 되도록 건조하여 발효 흑삼을 제조 하였다. Fermented ginseng was prepared by inoculating the dried ginseng with moisture and white koji mold (Aspergillus awamori var. It was dried as much as possible to prepare fermented black ginseng .

제조된 흑삼을 70%(V/V) ethanol에 1 : 10의 비율로 넣어 80℃에서 8시간 씩 2회 추출하였으며, 추출한 후 5㎛ 정성여과지 (No.1, Advantec MFS Inc., Dubiln, CA, USA)를 사용하여 여과하였다. 여과된 추출액을 감압농축기를 이용하여 농축 후 소재로 사용하였다. The prepared black ginseng was added to 70% (V/V) ethanol in a ratio of 1:10 and extracted twice at 80°C for 8 hours each . After extraction, 5㎛ qualitative filter paper (No.1, Advantec MFS Inc., Dubiln, CA) , USA) was used for filtration. The filtered extract was concentrated using a reduced pressure concentrator and then used as a material.

2. 발효해삼 제조2. Manufacture of fermented sea cucumber

해삼(Stichopus japonicus)은 충남 보령시 및 태안군등 서해안 자생 해삼을 구입하여 건조, 자숙 및 발효과정을 거쳐 발효해삼을 제조하여 추출 및 농축하여 사용하였다. 건조해삼(DS)은 재수화하였으며, 생해삼은 찌기(SS)와 자숙(BS)하여 3 가지 시료를 본 실험에 사용하였다. Sea cucumber (Stichopus japonicus) was purchased from Boryeong-si and Taean-gun, Chungcheongnam-do, and dried, self-fermented and fermented to produce fermented sea cucumber, extracted and concentrated. Dried sea cucumber (DS) was rehydrated, and raw sea cucumber was steamed (SS) and self-fertilized (BS), and three samples were used in this experiment.

해삼은 백국균(white-koji mould)을 이용하여 발효하였다. 원료의 수분함량을 60%로 조정 후 멸균기에서 멸균 후 원료 무게의 1, 2, 3%의 백국균(white-koji mould)을 각각 첨가하여 30℃에서 0, 24, 36, 48, 60, 72 시간 발효하여 산성다당체 함량을 측정하여 발효조건을 결정하였다.Sea cucumber was fermented using white-koji mold. After adjusting the moisture content of the raw material to 60% and sterilizing it in a sterilizer, 1, 2, 3% of white-koji mold of the raw material weight is added, respectively, and 0, 24, 36, 48, 60, 72 at 30℃ Fermentation conditions were determined by measuring the acid polysaccharide content by time fermentation.

해삼 발효물은 10배수의 멸균수를 넣어 60℃에서 추출하여 추출액을 감압농축하여 발효 농축액을 제조하여 실험에 사용하였다. The fermented sea cucumber was extracted at 60°C by adding 10 times of sterilized water, and the extract was concentrated under reduced pressure to prepare a fermented concentrate and used in the experiment.

3. 산성다당체 측정3. Measurement of acid polysaccharides

발효해삼(SJF) 및 발효흑삼(BGF)의 산성다당체 함량은 3-phenylphenol법(Choi et al., 2014)으로 측정하였다. 추출물 0.1 g에 10 mL의 증류수를 첨가한 다음 초고속 원심분리기를 이용하여 7,000 rpm에서 15분 동안 원심분리를 한 후 여과지(Whatman No 1.)로 여과한 다음 사용하였다. 추출물 1 g에 5 mL의 0.0125 M sodium tetraborate/H2SO4를 첨가한 후 항온수조에서 100°C, 5분 동안 가열하고 15분 동안 냉각시켰다. 1 mL의 0.15% 3-phenyl-phenol/0.5% NaOH를 첨가한 후 분광광도계를 이용하여 520 nm에서 측정하였다. 표준곡선은 galacturonic acid를 이용하여 0~100 μg/g으로 측정하였다.The acidic polysaccharide content of fermented sea cucumber (SJF) and fermented black ginseng (BGF) was measured by the 3-phenylphenol method (Choi et al., 2014). 10 mL of distilled water was added to 0.1 g of the extract, followed by centrifugation at 7,000 rpm for 15 minutes using an ultra-high speed centrifuge, followed by filtration with filter paper (Whatman No. 1.). After adding 5 mL of 0.0125 M sodium tetraborate/H2SO4 to 1 g of the extract, it was heated in a constant temperature water bath at 100°C for 5 minutes and cooled for 15 minutes. After adding 1 mL of 0.15% 3-phenyl-phenol/0.5% NaOH, it was measured at 520 nm using a spectrophotometer. The standard curve was measured at 0-100 μg/g using galacturonic acid.

4. 진세노사이드 분석4. Ginsenoside Analysis

시료 1.0 g을 농축용 플라스크에 평량해 넣고 70% 메탄올 50 mL을 첨가하고 80℃ 환류냉각추출기에서 1시간 추출하였으며, 10분간 방냉 후 추출액을 여과하고, 잔사에 다시 동량의 용매를 넣어 2회 반복 추출하였다. 추출물을 농축플라스크에 모아 45℃ 수조에서 rotary evaporator를 이용하여 진공 농축하였다. 농축 후 플라스크 내 잔류물을 10 mL 증류수에 녹여 0.45 ㎛ membrane filter로 여과하였다. Ginsenoside 함량 측정은 HPLC (Agilent 1260, Agilent Technologies, USA)를 이용하여 측정하였다. HPLC 분석은 Agilent poroshell 120EC-C18 (3.0 mm × 50 mm, 2.7 ㎛) column을 사용하여 표와 같이 이동상의 유속과 컬럼 온도는 각각 0.8 ㎖/min, 35℃로 하고, UV 검출기의 검출 파장은 203 nm로 하여 분석하였다. (하기의 표 1 : HPLC 이동상 조건)Weigh 1.0 g of the sample into a concentration flask, add 50 mL of 70% methanol, extract for 1 hour in a reflux condenser at 80 °C, cool for 10 minutes, filter the extract, add the same amount of solvent to the residue, and repeat twice extracted. The extracts were collected in a concentration flask and concentrated in vacuo using a rotary evaporator in a water bath at 45°C. After concentration, the residue in the flask was dissolved in 10 mL distilled water and filtered through a 0.45 μm membrane filter. Ginsenoside content was measured using HPLC (Agilent 1260, Agilent Technologies, USA). For HPLC analysis, an Agilent poroshell 120EC-C18 (3.0 mm × 50 mm, 2.7 μm) column was used. As shown in the table, the flow rate and column temperature of the mobile phase were 0.8 ml/min and 35°C, respectively, and the detection wavelength of the UV detector was 203 Analyzed in nm. (Table 1: HPLC mobile phase conditions)

Time (min)Time (min) Acetonitrile (%)Acetonitrile (%) Water (%)Water (%) 00 55 9595 22 55 9595 44 1111 8989 99 1313 5757 1919 2121 7979 2626 2828 7272 2828 2828 7272 3232 3232 6868 3434 3232 6868 4040 4545 5555 4242 4545 5555 5050 5555 4545 5555 5555 4545 6262 55 9595

5. 대식세포 배양5. Macrophage Culture

마우스 유래의 대식세포주인 Raw264.7 cell은 한국세포주은행(Seoul, Korea)에서 분양받아 사용했으며, 세포배양을 위해 100 unit/mL penicillin 및 100 unit/mL streptomycin과 10% fetal bovine serum을 포함하는 Dulbecco’s modified Eagle’s medium(Lonza, Walkersville, MD, USA)을 사용했고, 세포는 37°C, 5% CO2 incubator(Thermo, Carlsbad, CA, USA)에서 배양하였다.The mouse-derived macrophage cell line, Raw264.7 cell, was purchased from the Korea Cell Line Bank (Seoul, Korea) and used for cell culture by Dulbecco's containing 100 unit/mL penicillin and 100 unit/mL streptomycin and 10% fetal bovine serum. Modified Eagle's medium (Lonza, Walkersville, MD, USA) was used, and cells were incubated at 37°C and 5% CO2 incubator (Thermo, Carlsbad, CA, USA).

6. 대식세포 생존율 평가6. Assessment of macrophage viability

해삼복합소재(SJBG-F)의 처리가 대식세포 생존율에 미치는 영향을 측정하기 위하여 대식세포를 96-well plate에 1×104 cells/well의 농도로 분주하고 37℃, 5% CO2 incubator에서 15시간 동안 배양하면서 세포를 완전히 부착시킨 후, 해삼, 흑삼 및 해삼복합소재를 각각 희석배율에 따라 처리한 뒤 37℃로 유지되는 5% CO2 세포 배양기에서 24시간 배양한 후, 대식세포 생존율을 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT; Sigma-Aldrich Co., St. Louis, MO, USA) 방법에 의하여 측정하였다. MTT 시약을 PBS에 5 mg/mL의 농도로 용해하여 well당 30 μL씩 첨가하고 2시간 동안 반응시킨 후, 배양 상등액를 제거하고 세포 내 생성된 formazan crystal을 dimethyl sulfoxide (DMSO; Sigma-Aldrich Co.)에 녹여 570 nm에서 흡광도를 측정하였다.To measure the effect of treatment with sea cucumber composite (SJBG-F) on macrophage viability, macrophages were aliquoted in a 96-well plate at a concentration of 1×10 4 cells/well and placed at 37°C, 5% CO2 incubator for 15 minutes. After the cells were completely attached while culturing for an hour, sea cucumber, black ginseng, and sea cucumber composite were treated according to the dilution ratio, respectively, and then cultured for 24 hours in a 5% CO2 cell incubator maintained at 37 ° C. (4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT; Sigma-Aldrich Co., St. Louis, MO, USA) was measured by the method. MTT reagent was dissolved in PBS at a concentration of 5 mg/mL, 30 μL per well was added, and after reacting for 2 hours, the culture supernatant was removed and the formazan crystal generated in the cell was dimethyl sulfoxide (DMSO; Sigma-Aldrich Co.) The absorbance was measured at 570 nm.

7. 대식세포 세포 독성 평가7. Macrophage Cytotoxicity Assessment

해삼복합소재(SJBG-F)로 인한 세포사멸을 분석하기 위해 FITC Annexin V Apoptosis Detection Kit I(BD Biosciences, San Diego, CA, USA)을 이용해 측정하였다. 세포를 PBS로 세척한 후 Annexin V binding buffer를 이용하여 5×105 cells/mL 농도로 현탁시켰다. 이 용액으로부터 100 μL(1×105 cells)의 세포를 채취하여 5 mL culture tube에 분주하고, Annexin V-FITC(5 μL)와 PI-PE(5 μL)를 첨가하여 20분 동안 상온에서 염색을 실시한다. 염색된 혼합액에 Annexin V binding buffer(400 μL)를 첨가한 후 flow cytometer(BD FACSVerseTM; BD Biosciences) 분석을 실시하였다. 분석 후에 나온 데이터는 FlowJo software(V10, Tree Star, Ashland, OR, USA)를 사용해 평가하였다.To analyze apoptosis caused by sea cucumber composite (SJBG-F), it was measured using FITC Annexin V Apoptosis Detection Kit I (BD Biosciences, San Diego, CA, USA). After washing the cells with PBS, the cells were suspended at a concentration of 5×10 5 cells/mL using Annexin V binding buffer. 100 μL (1×10 5 cells) of cells are collected from this solution, aliquoted into a 5 mL culture tube, and stained at room temperature for 20 minutes by adding Annexin V-FITC (5 μL) and PI-PE (5 μL). carry out After adding Annexin V binding buffer (400 μL) to the stained mixture, flow cytometer (BD FACSVerse™; BD Biosciences) analysis was performed. Data obtained after analysis were evaluated using FlowJo software (V10, Tree Star, Ashland, OR, USA).

8. 대식세포 활성산소종(Reactive oxygen species; ROS) 측정8. Measurement of macrophage reactive oxygen species (ROS)

세포 내 활성산소종은 2’,7’-dichlorodihydrofluorescein diacetate(H2DCFDA; Molecular Probes, Eugene, OR, USA)로 세포를 염색하여 확인하였다. H2DCFDA가 세포 안으로 침투할 때 가수분해에 의해 dichlorofluorescein diacetate로 전환되고 활성산소종과 반응하여 dichlorofluorescein으로 산화되어 녹색의 형광을 발하게 된다. 세포에 H2DCFDA 10 μM을 37°C에서 30분간 염색한 후 PBS로 세척한 다음 flow cytometer(BD FACSVerseTM; BD Biosciences) 분석을 실시하였다. 분석 후에 나온 데이터는 FlowJo software를 사용하여 평가하였다.Intracellular reactive oxygen species were identified by staining the cells with 2',7'-dichlorodihydrofluorescein diacetate (H2DCFDA; Molecular Probes, Eugene, OR, USA). When H2DCFDA penetrates into the cell, it is converted to dichlorofluorescein diacetate by hydrolysis and reacts with reactive oxygen species to be oxidized to dichlorofluorescein and emit green fluorescence. Cells were stained with 10 µM of H2DCFDA at 37 °C for 30 minutes, washed with PBS, and then analyzed by flow cytometer (BD FACSVerse™; BD Biosciences). Data obtained after analysis were evaluated using FlowJo software.

9. 대식세포 사이토카인(cytokine) 분비능 측정9. Measurement of macrophage cytokine secretion

해삼복합소재(SJBG-F)로 인한 대식세포 사이토카인 분비능을 측정하기 위하여 대식세포를 24 well plate에 well당 1×105 개로 분주하고 15시간 동안 배양한 다음, 발효해삼(SJF), 발효흑삼(BGF) 및 해삼복합소재(SJBG-F)를 각각 희석배율에 따라 처리한 뒤, 37℃, 5% CO2 incubator에서 24시간 배양한 후, 배양 상등액에 포함되어 있는 사이토 카인(TNF-α, IL-6 및 IL-1β)의 함량을 측정하였다. 사이토카인의 측정은 enzyme linked immunosorbent assay (ELISA) kit (BD Biosciences)를 사용하여 측정하였다.To measure macrophage cytokine secretion by sea cucumber complex (SJBG-F), macrophages were aliquoted into 1×10 5 per well in a 24 well plate and cultured for 15 hours, followed by fermented sea cucumber (SJF) and fermented black ginseng. (BGF) and sea cucumber composite material (SJBG-F) were treated according to the dilution ratio, respectively, and then incubated for 24 hours at 37°C, 5% CO2 incubator, and cytokines (TNF-α, IL -6 and IL-1β) were measured. Cytokines were measured using an enzyme linked immunosorbent assay (ELISA) kit (BD Biosciences).

10. 대식세포 산화질소(nitric oxide; NO) 분비능 측정10. Measurement of nitric oxide (NO) secretion ability in macrophages

분리된 배양 상층액 100 μL에 동량의 Griess(Sigma-Aldrich) 시약을 처리하여 10분 동안 반응시킨 후 마이크로플레이트 판독기(BioTek)를 이용하여 540 nm에서 흡광도를 측정하였다. 산화질소의 농도는 아질산소듐(NaNO2, Sigma-Aldrich)을 사용하여 얻은 표준 직선과 비교하여 산출하였다.100 μL of the separated culture supernatant was treated with the same amount of Griess (Sigma-Aldrich) reagent and reacted for 10 minutes, and then absorbance was measured at 540 nm using a microplate reader (BioTek). The concentration of nitric oxide was calculated by comparing it with a standard straight line obtained using sodium nitrite (NaNO2, Sigma-Aldrich).

11. Western blot analysis11. Western blot analysis

대식세포 Raw264.7를 6-well plate에 1×106 cell/well의 농도로 분주하여 15시간 동안 완전히 부착시키고 발효해삼(SJF), 발효흑삼(BGF) 및 해삼복합소재(SJBG-F)를 각각 처리하였다. 배양이 끝난 세포를 수집하여 PBS로 3회 세척한 후 NP40 cell lysis buffer(Biosource, Seoul, Korea)를 첨가한 뒤 13,000 rpm에서 15분간 원심분리해서 cell lysis를 분리하였다. 핵 내의 단백질을 분리하기 위하여, 상기 수집된 세포에 저장성 완충용액(10 mM HEPES, pH 7.9, 1.5 mM magnesium chloride(MgCl2), 10 mM potassium chloride(KCl), 0.5 mM dithiothreitol(DTT), 1 μM leupeptin 및 0.2 mM phenyl methyl sulfonyl fluoride(PMSF))을 20분간 처리한 후 12,000 rpm에서 1분간 원심분리하여 세포질과 핵을 분리하였으며, 분리된 핵을 고장성 완충액(20 mM HEPES, pH 7.9, 25% glycerol, 420 mM ethylene diaminetetraacetic acid(EDTA), 0.5 mM DTT, 1 μM leupeptin, 0.2 mM PMSF)을 처리하여 12,000 rpm에서 20분간 원심분리하여 핵 단백질을 추출하였다. 분리된 cell lysate는 BCA protein detection kit(Thermo scientific, Rockford, IL, USA)를 사용하여 단백질 정향을 실시하였고, well 당 10 μg의 cell lysate를 폴리아크릴아마이드 젤에 각각 loading하여 SDS-PAGE로 변성분리하였다. 그 다음, polyvinylidene difluoride(PVDF) membrane(Millipore Merck KGaA, Darmstadt, Germany)으로 transfer하였고, membrane은 항체의 비특이적 결합을 방지하기 위해 blocking solution(5% skim milk solution)에서 1시간 방치하였다. 이후 TBST(20 mM Tris-HCl, 150 mM NaCl, 0.1% Tween-20, pH 7.5)로 10분씩 3회 세척한 후, Cox-2, iNOS, p-ERK1/2, p-p38, p-IκBα 및 NF-κB의 발현량을 측정하기 위해 1차 항체(Cell signaling, Danvers, MN, USA)를 1:2,000으로 희석하여 4°C에서 15시간 동안 반응시킨 다음, TBST로 10분씩 3∼5회 세척한 뒤, 2차 항체(goat-anti rabbit IgG; Calbiochem, La Jolla, CA, USA)를 1:5,000으로 희석하여 1시간 반응시켰다. 그 다음 TBST로 10분씩 3∼5회 세척한 뒤, 현상을 위하여 electrochemiluminescence(ECL; Millipore Merck KGaA) reagent를 사용하여 인화하였다.Macrophage Raw264.7 was dispensed into a 6-well plate at a concentration of 1×10 6 cells/well, completely adhered for 15 hours, and fermented sea cucumber (SJF), fermented black ginseng (BGF) and sea cucumber composite material (SJBG-F) each was treated. After culturing cells were collected, washed 3 times with PBS, NP40 cell lysis buffer (Biosource, Seoul, Korea) was added, and then centrifuged at 13,000 rpm for 15 minutes to separate cell lysis. To isolate proteins in the nucleus, hypotonic buffer solution (10 mM HEPES, pH 7.9, 1.5 mM magnesium chloride (MgCl2), 10 mM potassium chloride (KCl), 0.5 mM dithiothreitol (DTT), 1 μM leupeptin) in the collected cells. and 0.2 mM phenyl methyl sulfonyl fluoride (PMSF)) for 20 minutes, centrifugation at 12,000 rpm for 1 minute to separate the cytoplasm and nucleus, and the separated nucleus in hypertonic buffer (20 mM HEPES, pH 7.9, 25% glycerol) , 420 mM ethylene diaminetetraacetic acid (EDTA), 0.5 mM DTT, 1 μM leupeptin, 0.2 mM PMSF) and centrifuged at 12,000 rpm for 20 minutes to extract nuclear proteins. The separated cell lysate was subjected to protein orientation using the BCA protein detection kit (Thermo scientific, Rockford, IL, USA), and 10 μg of cell lysate per well was loaded into polyacrylamide gel, respectively, and denatured separation was performed by SDS-PAGE. did. Then, it was transferred to a polyvinylidene difluoride (PVDF) membrane (Millipore Merck KGaA, Darmstadt, Germany), and the membrane was left in a blocking solution (5% skim milk solution) for 1 hour to prevent non-specific binding of the antibody. Then, after washing 3 times with TBST (20 mM Tris-HCl, 150 mM NaCl, 0.1% Tween-20, pH 7.5) for 10 min each, Cox-2, iNOS, p-ERK1/2, p-p38, p-IκBα And in order to measure the expression level of NF-κB, the primary antibody (Cell signaling, Danvers, MN, USA) was diluted 1:2,000 and reacted at 4 °C for 15 hours, and then 3 to 5 times with TBST for 10 minutes each. After washing, the secondary antibody (goat-anti rabbit IgG; Calbiochem, La Jolla, CA, USA) was diluted 1:5,000 and reacted for 1 hour. Then, it was washed 3 to 5 times for 10 minutes with TBST, and then printed using an electrochemiluminescence (ECL; Millipore Merck KGaA) reagent for development.

12. 세포 표면 활성 인자(cell surface marker) 발현 확인12. Confirmation of cell surface marker expression

해삼복합소재(SJBG-F)의 처리가 대식세포의 세포 표면 활성 인자 발현에 미치는 영향을 측정하기 위하여 대식세포를 12-well plate에 well당 2×105개로 분주한 후, 발효해삼(SJF), 발효흑삼(BGF) 및 해삼복합소재(SJBG-F)를 각각 처리한 후 24시간 동안 반응시키고 각각의 세포를 회수하였다. 항체의 비특이적인 결합을 방지하기 위하여 회수된 각각의 세포에 1μg/mL의 Fcγ Ⅰ/Ⅲ (BD Biosciences)을 처리하여 4°C에서 20분간 반응시킨 후, 세포 표면 활성 인자 분석을 위하여 anti-CD80-PE, anti-CD86-APC, anti-MHC-Ⅰ-PE 및 anti-MHC-Ⅱ-PE (BD Biosciences)와 같은 세포 표면 항체를 각각 1,000배 희석하여 각각의 세포에 처리하여 30분 동안 반응시키고 flow cytometer(BD FACSVerseTM; BD Biosciences)를 이용하여 분석하였다. 분석 후에 나온 데이터는 FlowJo software를 사용하여 평가하였다.To measure the effect of the treatment of sea cucumber composite (SJBG-F) on the expression of cell surface activators of macrophages, macrophages were aliquoted into 2×10 5 per well in a 12-well plate, and then fermented sea cucumber (SJF) , fermented black ginseng (BGF) and sea cucumber composite material (SJBG-F) were treated and reacted for 24 hours, and each cell was recovered. In order to prevent non-specific binding of the antibody, each recovered cell was treated with 1 μg/mL Fcγ I/III (BD Biosciences) and reacted at 4 °C for 20 minutes, and then anti-CD80 for cell surface activation factor analysis. -PE, anti-CD86-APC, anti-MHC-I-PE, and anti-MHC-II-PE (BD Biosciences), respectively, diluted 1,000-fold with cell surface antibodies, treated with each cell, and reacted for 30 minutes. Analysis was performed using a flow cytometer (BD FACSVerse™; BD Biosciences). Data obtained after analysis were evaluated using FlowJo software.

13. 통계처리13. Statistical processing

이상의 실험에서 얻어진 결과는 통계학적 소프트웨어(GraphPad Prism Software, version 4.03; GraphPad Software, San Diego, CA, USA)를 사용하여 Tukey’s multiple comparison test에 이어 one-way ANOVA test로 분석하였으며, 시료 간의 유의성은 Duncan’s multiple range test로 P<0.05, P<0.01 및 P<0.001 수준에서 비교하였다.The results obtained in the above experiments were analyzed by one-way ANOVA test followed by Tukey's multiple comparison test using statistical software (GraphPad Prism Software, version 4.03; GraphPad Software, San Diego, CA, USA). Comparisons were made at the levels of P<0.05, P<0.01 and P<0.001 by multiple range test.

실험예 2. 실험결과 및 분석Experimental Example 2. Experimental results and analysis

1. 발효흑삼(BGF)의 산성다당체 함량1. Acidic polysaccharide content of fermented black ginseng (BGF)

인삼의 면역증진의 기능성은 인삼 성분 중 사포닌 및 다당체에 의한 효능 연구도 많이 보고되어 있다. 동물실험결과 홍삼에서 분리한 홍삼산성다당체는 생체의 면역력을 증진 시킨다고 알려져 있다. The efficacy of ginseng for enhancing immunity by saponins and polysaccharides among ginseng components has also been reported in many studies. As a result of animal testing, it is known that red ginseng acid polysaccharide isolated from red ginseng enhances the immune system of the body.

실험결과, 발효 전 백삼(W.G), 홍삼(R.G), 흑삼(B.G)의 추출물의 산성다당체 함량은 백삼 15.0%, 홍삼 15.2%, 흑삼 17.3%에서 발효를 통해 백삼(F.W.G) 18.2%, 홍삼(F.R.G) 19.2%, 흑삼(F.B.G) 21.3%로 증가되는 것으로 분석되었다.As a result of the experiment, the acid polysaccharide content of the extracts of white ginseng (W.G), red ginseng (R.G), and black ginseng (B.G) before fermentation was 15.0% of white ginseng, 15.2% of red ginseng, and 17.3% of black ginseng. F.R.G) was analyzed to increase by 19.2% and black ginseng (F.B.G) by 21.3%.

발효를 통해 흑삼에서 최고 21-25%의 산성다당체 추출율 증가 효과를 볼 수 있었으며 환원당 역시 발효 전 백삼 11.9%, 홍삼 14.8%, 흑삼 13.2%의 수율에서 발효를 통해 백삼 22.3%, 홍삼 26.8%, 흑삼 28.1%의 증가를 보였으며, 흑삼에서 최고 80-110%의 환원당 증가 효과를 볼 수 있었다(도 1 참조) Through fermentation, it was possible to see the effect of increasing the extraction rate of acidic polysaccharides by up to 21-25% from black ginseng, and reducing sugars were also fermented at the yields of 11.9%, 14.8%, and 13.2% of white ginseng before fermentation, white ginseng 22.3%, red ginseng 26.8%, and black ginseng. It showed an increase of 28.1%, and it was possible to see the effect of increasing reducing sugar by up to 80-110% in black ginseng (see Fig. 1).

2. 발효해삼(SJF)의 산성다당체 함량2. Acidic polysaccharide content of fermented sea cucumber (SJF)

해삼의 산성다당체는 균 접종량과 발효시간에 따라 26.14-74.21%의 범위로 측정되었다(도 2 참조). 백국균(white-koji mould) 발효에서 산성다당체 함량이 높게 측정되었으며, 균 접종량과 발효시간에 따라서는 증가와 감소의 패턴이 나타났다. The acidic polysaccharide of sea cucumber was measured in the range of 26.14-74.21% according to the bacterial inoculation amount and fermentation time (see FIG. 2). Acidic polysaccharide content was measured to be high in white-koji mold fermentation, and a pattern of increase and decrease was observed depending on the bacterial inoculation amount and fermentation time.

본 실험에서는 건조해삼에 대하여 백국균(white-koji mould) 1% 첨가군에서 60시간 발효하였을 때 가장 높은 산성다당체 함량을 나타내었으며 발효에 의해 산성다당체 함량이 증가하는 것으로 나타났다. In this experiment, when fermented for 60 hours in the group with 1% white-koji mold for dried sea cucumber, the highest acidic polysaccharide content was exhibited, and the acidic polysaccharide content was increased by fermentation.

3. 발효흑삼의 진세노사이드 함량 변화3. Changes in ginsenoside content of fermented black ginseng

백국균(white-koji mould)을 이용한 발효 흑삼에서는 흑삼 특유 진세노사이드인 Rg3, Rg5, Rk1 함량이 증가 되는 것을 볼 수 있었다. In fermented black ginseng using white-koji mold, the contents of Rg3, Rg5, and Rk1, which are ginsenosides unique to black ginseng, were increased .

백국균(white-koji mould) 발효를 통해, 백삼에서 지표물질 Rg3, Rg5, Rk1의 함량이 0 mg/g, 홍삼에서는 1.3 mg/g, 흑삼에서는 1.9 mg/g 그리고 발효흑삼에서는 4.13 mg/g으로 증가하는 결과를 볼 수 있었다. (도 3 및 도 4 참조)Through white-koji mold fermentation, the content of indicator substances Rg3, Rg5, and Rk1 in white ginseng is 0 mg/g, in red ginseng 1.3 mg/g, in black ginseng 1.9 mg/g, and in fermented black ginseng 4.13 mg/g increased results could be seen. (See Figs. 3 and 4)

4. 세포 생존율 평가4. Assessing Cell Viability

발효해삼(SJF, 발효해삼 추출물, 건조해삼에 백국균 1% 첨가 60시간 발효 후60℃ 멸균수 추출), 발효흑삼(BGF, 발효흑삼 추출물, 백군균 발효 70%(V/V) 에탄올 추출) 및 해삼복합소재(SJBG-F, 발효해삼 추출물:발효흑삼 추출물 = 3:7 중량비로 혼합)의 세포독성 여부를 확인하기 위하여 대식세포 Raw264.7 cell에 각각 희석배수별(200X, 400X, 800X, 1600X, 3200X, 6400X)로 처리하여 세포 생존율을 MTT 방법을 통하여 평가하였다. Fermented sea cucumber (SJF, fermented sea cucumber extract, dried sea cucumber with 1% added white koji bacteria extracted at 60℃ after fermentation for 60 hours), fermented black ginseng (BGF, fermented black ginseng extract, white group bacteria fermentation 70% (V/V) ethanol extraction) and sea cucumber composite material (SJBG-F, fermented sea cucumber extract: fermented black ginseng extract = mixed in a weight ratio of 3:7) were cytotoxic to macrophage Raw264.7 cells by dilution factor (200X, 400X, 800X, 1600X, 3200X, 6400X) and the cell viability was evaluated through the MTT method.

그 결과 발효해삼은 희석배수 200X 및 400X에서 세포독성이 나타났지만 800X부터는 세포독성이 나타나지 않았으며(도 5A), 흑삼 및 해삼복합소재의 경우 희석배수 1600X까지 세포독성이 나타났지만 3200X부터는 세포독성이 나타나지 않았다(도 5B, C). As a result, fermented sea cucumber showed cytotoxicity at dilutions of 200X and 400X, but did not show cytotoxicity from 800X (Fig. 5A). did not appear (Fig. 5B, C).

따라서 추후 발효해삼(SJF), 발효흑삼(BGF) 및 해삼복합소재(SJBG-F)의 면역활성 비교 평가를 위해서 세포독성이 나타나지 않는 희석배수 3200X으로 고정하여 실험하였다. Therefore, for the comparative evaluation of immune activity of fermented sea cucumber (SJF), fermented black ginseng (BGF) and sea cucumber composite material (SJBG-F) later, it was fixed at a dilution factor of 3200X that does not show cytotoxicity and tested.

5. 세포사멸(apoptosis) 평가5. Assessment of apoptosis

고정된 희석배수 3200X의 발효해삼, 발효흑삼 및 해삼복합소재(SJBG-F)로 인한 세포사멸(apoptosis) 여부를 확인하기 위하여 대식세포 Raw264.7 cell에 희석배수 3200X의 발효해삼(SJF), 발효흑삼(BGF) 및 해삼복합소재(SJBG-F)를 각각 처리한 뒤 Annexin V/PI staining analysis를 통하여 평가하였다(도 6 참조).Fermented sea cucumber (SJF) at a dilution factor of 3200X in macrophage Raw264.7 cells to check whether apoptosis caused by fermented sea cucumber, fermented black ginseng and sea cucumber composite (SJBG-F) at a fixed dilution factor of 3200X Black ginseng (BGF) and sea cucumber composite material (SJBG-F) were respectively treated and evaluated through Annexin V/PI staining analysis (see FIG. 6 ).

그 결과 희석배수 3200X의 발효해삼(SJF), 발효흑삼(BGF) 및 해삼복합소재(SJBG-F) 모두 세포사멸을 일으키지 않았으며, 이는 희석배수 3200X에서는 세포독성이 나타나지 않는다는 것을 확인할 수 있었다.As a result, fermented sea cucumber (SJF), fermented black ginseng (BGF), and sea cucumber composite (SJBG-F) at a dilution factor of 3200X did not cause apoptosis, and it was confirmed that cytotoxicity was not observed at the dilution factor 3200X.

6. 활성산소종(reactive oxygen species; ROS) 평가6. Reactive oxygen species (ROS) evaluation

활성산소종은 생체 내에 산화 생성을 합성하며 이렇게 생성된 산화물질은 생체에 치명적인 독성을 일으킨다고 알려져 있기(Rao & Balachandran, 2002)에 본 실험에서는 발효해삼(SJF), 발효흑삼(BGF) 및 해삼복합소재(SJBG-F)로 인한 활성산소종의 생성 여부를 확인하기 위하여 대식세포 Raw264.7 cell에 희석배수 3200X의 발효해삼(SJF), 발효흑삼(BGF) 및 해삼복합소재(SJBG-F)를 각각 처리한 뒤 H2DCFDA를 세포에 염색하여 측정하였다(도 7 참조).Reactive oxygen species synthesize oxidative production in the living body, and the oxidized substances produced in this way are known to cause fatal toxicity to the living body (Rao & Balachandran, 2002), so in this experiment, fermented sea cucumber (SJF), fermented black ginseng (BGF) and Fermented sea cucumber (SJF), fermented black ginseng (BGF), and sea cucumber composite material (SJBG-F) at a dilution factor of 3200X in macrophage Raw264.7 cells to check whether reactive oxygen species are generated by the composite material (SJBG-F). After each treatment, H2DCFDA was measured by staining the cells (see FIG. 7).

그 결과, 발효해삼(SJF), 발효흑삼(BGF) 및 해삼복합소재(SJBG-F) 모두 활성산소종이 증가하지 않는 것을 확인할 수 있었다.As a result, it was confirmed that active oxygen species did not increase in all of fermented sea cucumber (SJF), fermented black ginseng (BGF) and sea cucumber composite material (SJBG-F).

7. 사이토카인(cytokine) 분비능 비교7. Comparison of cytokine secretion

사이토카인은 면역세포 간 상호작용을 매개하여 신호전달을 위한 중요한 면역조절인자(Byun & Byun, 2015)이며 대식세포의 대표적인 사이토카인은 TNF-α, IL-6 및 IL-1β 등이 있다. Cytokines are important immunomodulators for signal transduction by mediating interactions between immune cells (Byun & Byun, 2015), and representative cytokines of macrophages include TNF-α, IL-6 and IL-1β.

본 실험에서는 발효해삼(SJF), 발효흑삼(BGF) 및 해삼복합소재(SJBG-F)로 인한 대식세포 면역활성에 미치는 영향을 비교 평가하기 위하여 대식세포 Raw264.7 cell에 희석배수 3200X의 발효해삼(SJF), 발효흑삼(BGF) 및 해삼복합소재(SJBG-F)를 각각 처리한 뒤 사이토카인 TNF-α, IL-6 및 IL-1β의 분비능을 측정해보았다(도 8 참조).In this experiment, in order to compare and evaluate the effects of fermented sea cucumber (SJF), fermented black ginseng (BGF) and sea cucumber composite material (SJBG-F) on macrophage immune activity, fermented sea cucumber with a dilution factor of 3200X in macrophage Raw264.7 cells. (SJF), fermented black ginseng (BGF) and sea cucumber composite material (SJBG-F) were treated, respectively, and the secretion ability of the cytokines TNF-α, IL-6 and IL-1β was measured (see FIG. 8).

그 결과 전반적으로 발효해삼(SJF), 발효흑삼(BGF) 및 해삼복합소재(SJBG-F) 모두 사이토카인 TNF-α, IL-6 및 IL-1β의 분비능이 증가하였으며, 특히 해삼복합소재(SJBG-F)의 사이토카인 분비능이 월등히 높게 증가하였다. 따라서 해삼복합소재(SJBG-F)의 면역활성으로 인한 사이토카인 분비능이 발효해삼(SJF) 및 발효흑삼(BGF)보다 높다는 것을 확인할 수 있었다.As a result, fermented sea cucumber (SJF), fermented black ginseng (BGF), and sea cucumber complex (SJBG-F) all showed increased secretion of cytokines TNF-α, IL-6 and IL-1β, and in particular, sea cucumber complex (SJBG) -F) increased cytokine secretion significantly. Therefore, it was confirmed that the cytokine secretion ability due to the immune activity of the sea cucumber complex (SJBG-F) was higher than that of the fermented sea cucumber (SJF) and the fermented black ginseng (BGF) .

8. Cox-2 및 iNOS 관련 산화질소(nitric oxide; NO) 분비능 비교8. Comparison of nitric oxide (NO) secretion in relation to Cox-2 and iNOS

산화질소는 대식세포의 활성화에 중요한 바이오마커로 사용(Flurkey, 1991; Gao et al., 2000; Jung & Park, 2005)되므로 발효해삼(SJF), 발효흑삼(BGF) 및 해삼복합소재(SJBG-F)로 인한 산화질소 분비능 및 산화질소 관련 단백질(Cox-2 및 iNOS)의 발현을 확인하였다. Since nitric oxide is used as an important biomarker for macrophage activation (Flurkey, 1991; Gao et al., 2000; Jung & Park, 2005), fermented sea cucumber (SJF), fermented black ginseng (BGF) and sea cucumber composite (SJBG- F) induced nitric oxide secretion and expression of nitric oxide-related proteins (Cox-2 and iNOS) were confirmed.

그 결과, 이전 사이토카인 결과와 유사하게 발효해삼(SJF), 발효흑삼(BGF) 및 해삼복합소재(SJBG-F) 모두 산화질소의 분비능이 증가하였으며, 특히 해삼복합소재(SJBG-F)의 산화질소 분비능이 월등히 높게 증가하였다(도 9 A 참조). As a result, similar to the previous cytokine results, fermented sea cucumber (SJF), fermented black ginseng (BGF) and sea cucumber composite (SJBG-F) all increased the secretion of nitric oxide, and in particular, oxidation of sea cucumber composite (SJBG-F) Nitrogen secretion was significantly increased (see FIG. 9A).

또한, 산화질소 관련 단백질 Cox-2 및 iNOS의 발현도 발효해삼(SJF), 발효흑삼(BGF) 및 해삼복합소재(SJBG-F) 모두 확인하였으며, 발효해삼(SJF), 발효흑삼(BGF) 및 해삼복합소재(SJBG-F)에서 Cox-2 및 iNOS의 발현이 가장 높은 것을 확인하였다(도 9 B 참조).In addition, the expression of nitric oxide-related proteins Cox-2 and iNOS were also confirmed in fermented sea cucumber (SJF), fermented black ginseng (BGF) and sea cucumber composite (SJBG-F), and fermented sea cucumber (SJF), fermented black ginseng (BGF) and It was confirmed that the expression of Cox-2 and iNOS was the highest in the sea cucumber composite (SJBG-F) (see FIG. 9B).

이로 인해 해삼복합소재(SJBG-F)는 발효해삼(SJF) 및 발효흑삼(BGF)보다 면역활성이 높아 산화질소 분비능도 높다는 것을 확인할 수 있었다. As a result, it was confirmed that the sea cucumber composite material (SJBG-F) had higher immune activity than fermented sea cucumber (SJF) and fermented black ginseng (BGF), and thus also had higher nitric oxide secretion .

9. MAPKs 인산화 및 NF-κB 발현 비교9. Comparison of MAPKs Phosphorylation and NF-κB Expression

Mitogen-activated protein kinases(MAPKs)와 nuclear factor(NF)-κB는 대식세포에서 면역활성을 매개하는 대표적인 신호전달 체계로서, 외부 자극에 의해 면역반응이 매개되면 대식세포 내부의 신호전달 체계가 활성화되면서 면역매개물질인 사이토카인과 산화질소 등의 분비가 촉진된다(Brewer et al., 1992). Mitogen-activated protein kinases (MAPKs) and nuclear factor (NF)-κB are representative signaling systems mediating immune activity in macrophages. The secretion of cytokines and nitric oxide, which are immune mediators, is promoted (Brewer et al., 1992).

대표적인 MAPKs의 단백질에는 세포 밖 조절 단백질 인산화효소(extracellular regulated protein kinase; ERK)와 세린/트레오닌 단백질 인산화효소(serine/threonine protein kinase; p38) 등이 있으며, 각 단백질의 인산화 유무에 따라 활성을 판단한다(Cobb & Goldsmith, 2000). Representative MAPKs proteins include extracellular regulated protein kinase (ERK) and serine/threonine protein kinase (p38), and their activity is determined according to the presence or absence of phosphorylation of each protein. (Cobb & Goldsmith, 2000).

본 실험에서는 발효해삼(SJF), 발효흑삼(BGF) 및 해삼복합소재(SJBG-F)로 인한 면역반응 메커니즘에 관하여 비교 분석하기 위하여, 발효해삼(SJF), 발효흑삼(BGF) 및 해삼복합소재(SJBG-F) 각각 처리된 세포 내 MAPKs(ERK1/2와 p38) 인산화와 NF-κB의 활성화에 관하여 확인하였다. In this experiment, fermented sea cucumber (SJF), fermented black ginseng (BGF) and sea cucumber composite material were used to compare and analyze the immune response mechanism caused by fermented sea cucumber (SJF), fermented black ginseng (BGF) and sea cucumber complex (SJBG-F). (SJBG-F) Phosphorylation of MAPKs (ERK1/2 and p38) and activation of NF-κB in each treated cell were confirmed.

대식세포 Raw264.7 cell에 희석배수 3200X의 발효해삼(SJF), 발효흑삼(BGF) 및 해삼복합소재(SJBG-F)를 각각 처리한 뒤 대식세포 내의 MAPKs의 인산화와 핵 내 NF-κB 발현을 관찰한 결과, 발효해삼(SJF), 발효흑삼(BGF) 및 해삼복합소재(SJBG-F) 모두 ERK1/2와 p38의 인산화가 유의적으로 증가하는 것이 관찰되었으며, 특히 해삼복합소재(SJBG-F)로 인한 ERK1/2와 p38의 인산화가 발효해삼(SJF) 및 발효흑삼(BGF)보다 높은 것이 관찰되었다(도 10 A 참조). Macrophage Raw264.7 cells were treated with fermented sea cucumber (SJF), fermented black ginseng (BGF) and sea cucumber composite (SJBG-F) at a dilution factor of 3200X, respectively, and then phosphorylation of MAPKs in macrophages and expression of NF-κB in the nucleus were observed. As a result of observation, it was observed that phosphorylation of ERK1/2 and p38 significantly increased in all of fermented sea cucumber (SJF), fermented black ginseng (BGF), and sea cucumber composite (SJBG-F), and in particular, in sea cucumber composite (SJBG-F) ), phosphorylation of ERK1/2 and p38 was observed to be higher than that of fermented sea cucumber (SJF) and fermented black ginseng (BGF) (see FIG. 10A).

또한, 핵 내 NF-κB 발현이 MAPKs 결과와 유사하게 증가되는 것이 관찰되었으며, NF-κB 발현도 해삼복합소재(SJBG-F)가 발효해삼(SJF) 및 발효흑삼(BGF)보다 높은 것이 관찰되었다(도 10 B 참조).In addition, it was observed that the NF-κB expression in the nucleus was increased similarly to the MAPKs result, and the NF-κB expression was also higher in sea cucumber composite (SJBG-F) than in fermented sea cucumber (SJF) and fermented black ginseng (BGF). (See Fig. 10B).

따라서 발효해삼(SJF), 발효흑삼(BGF) 및 해삼복합소재(SJBG-F)는 MAPKs의 인산화 및 NF-κB의 발현으로 인해 면역활성을 유도하며, 그 중 해삼복합소재(SJBG-F)가 가장 높은 면역활성을 유도하는 것을 확인할 수 있었다.Therefore , fermented sea cucumber (SJF), fermented black ginseng (BGF) and sea cucumber complex (SJBG-F) induce immune activity due to phosphorylation of MAPKs and expression of NF-κB, among which sea cucumber complex (SJBG-F) is It was confirmed that it induces the highest immune activity .

10. 세포 표면 활성 인자(cell surface marker) 발현 비교10. Comparison of cell surface marker expression

세포 표면 활성 인자(CD80, CD86, MHC class I과 II)의 발현은 대식세포의 활성화와 매우 밀접한 관련이 있으므로(Mo et al., 2017), 발효해삼(SJF), 발효흑삼(BGF) 및 해삼복합소재(SJBG-F)가 대식세포의 세포 표면 활성 인자의 발현량에 미치는 영향을 유세포 분석기를 이용하여 확인하였다. Since the expression of cell surface activating factors (CD80, CD86, MHC class I and II) is closely related to the activation of macrophages (Mo et al., 2017), fermented sea cucumber (SJF), fermented black ginseng (BGF) and sea cucumber The effect of the composite material (SJBG-F) on the expression level of the cell surface activator of macrophages was confirmed using flow cytometry.

대식세포 Raw264.7 cell에 희석배수 3200X의 발효해삼(SJF), 발효흑삼(BGF) 및 해삼복합소재(SJBG-F)를 각각 처리한 뒤 대식세포의 세포 표면 활성 인자(CD80, CD86, MHC class I과 II)의 발현을 관찰한 결과(도 11 참조), 발효해삼(SJF), 발효흑삼(BGF) 및 해삼복합소재(SJBG-F) 모두 CD80, CD86, MHC class I과 II의 발현이 증가하는 것이 관찰되었으며, 이전 결과와 유사하게 해삼복합소재(SJBG-F)가 발효해삼(SJF) 및 발효흑삼(BGF)보다 높게 발현되는 것이 관찰되었다.Macrophage Raw264.7 cells were treated with 3200X dilution factor of fermented sea cucumber (SJF), fermented black ginseng (BGF) and sea cucumber composite (SJBG-F), respectively, and then macrophage cell surface activation factors (CD80, CD86, MHC class) As a result of observing the expression of I and II) (see Fig. 11), the expression of CD80, CD86, and MHC class I and II was increased in all of fermented sea cucumber (SJF), fermented black ginseng (BGF) and sea cucumber composite (SJBG-F). Similar to the previous results, it was observed that the sea cucumber composite material (SJBG-F) was expressed higher than that of the fermented sea cucumber (SJF) and the fermented black ginseng (BGF).

이러한 결과로 보아 해삼복합소재(SJBG-F)가 발효해삼(SJF) 및 발효흑삼(BGF)보다 세포 표면 활성 인자 발현이 높아서 면역활성이 높은 것을 확인할 수 있었다.`Based on these results, it was confirmed that the sea cucumber composite material (SJBG-F) had higher cell surface activator expression than fermented sea cucumber (SJF) and fermented black ginseng (BGF) and thus had higher immune activity.`

11. 총괄분석11. Summative Analysis

발효 전 백삼, 홍삼, 흑삼의 추출물에서 산성다당체 함량은 백삼 15.0%, 홍삼 15.2%, 흑삼 17.3%로 분석되었으며 발효공정을 통해서 백삼 18.2%, 홍삼 19.2%, 흑삼 21.3%로 증가하는 것으로 분석되었다. 따라서 발효를 통해 발효흑삼(BGF)에서 최고 21-25%의 산성다당체 증가 효과를 볼 수 있었다. In the extracts of white ginseng, red ginseng, and black ginseng before fermentation, the acid polysaccharide content was analyzed to be 15.0% white ginseng, 15.2% red ginseng, and 17.3% black ginseng. Therefore, it was possible to see the effect of increasing the acidic polysaccharide by up to 21-25% in fermented black ginseng (BGF) through fermentation.

해삼의 산성다당체는 균 접종량과 발효시간에 따라 26.14-74.21%의 범위로 측정되었으며 백국균(white-koji mould) 1% 첨가군에서 60시간 발효하였을 때 가장 높은 산성다당체 함량을 나타내었다. The acidic polysaccharide content of sea cucumber was measured in the range of 26.14-74.21% depending on the bacterial inoculation amount and fermentation time.

백국균(white-koji mould)을 이용한 발효 흑삼에서는 흑삼 특유의 진세노사이드인 Rg3, Rg5, Rk1 함량이 증가 되는 것을 볼 수 있었다. In fermented black ginseng using white-koji mold, it was seen that the contents of Rg3, Rg5, and Rk1, which are ginsenosides unique to black ginseng, were increased.

대식세포를 이용한 활성산소종 측정에서 발효해삼(SJF), 발효흑삼(BGF) 및 해삼복합소재(SJBG-F) 모두 활성산소종이 증가하지 않는 것을 확인할 수 있었으며 해삼복합소재(SJBG-F)의 면역활성으로 인한 사이토카인(TNF-α, IL-6 , IL-1β) 분비능이 발효해삼(SJF) 및 발효흑삼(BGF)보다 높다는 것을 확인할 수 있었다. In the measurement of reactive oxygen species using macrophages, it was confirmed that active oxygen species did not increase in all of fermented sea cucumber (SJF), fermented black ginseng (BGF) and sea cucumber composite (SJBG-F). It was confirmed that the cytokine (TNF-α, IL-6, IL-1β) secretion ability due to immune activity was higher than that of fermented sea cucumber (SJF) and fermented black ginseng (BGF).

또한, 산화질소 관련 단백질 Cox-2 및 iNOS의 발현도 발효해삼(SJF), 발효흑삼(BGF) 및 해삼복합소재(SJBG-F) 모두 확인하였으며, 발효해삼(SJF), 발효흑삼(BGF) 및 해삼복합소재(SJBG-F)에서 Cox-2 및 iNOS의 발현이 가장 높은 것을 확인하였다. 이로 인해 해삼복합소재(SJBG-F)는 발효해삼(SJF) 및 발효흑삼(BGF)보다 면역활성이 높아 산화질소 분비능도 높다는 것을 확인할 수 있었다. In addition, the expression of nitric oxide-related proteins Cox-2 and iNOS were also confirmed in fermented sea cucumber (SJF), fermented black ginseng (BGF) and sea cucumber composite (SJBG-F), and fermented sea cucumber (SJF), fermented black ginseng (BGF) and It was confirmed that the expression of Cox-2 and iNOS was the highest in the sea cucumber composite (SJBG-F) . As a result, it was confirmed that the sea cucumber composite material (SJBG-F) had higher immune activity than fermented sea cucumber (SJF) and fermented black ginseng (BGF), and thus also had higher nitric oxide secretion.

해삼복합소재(SJBG-F)로 인한 ERK1/2와 p38의 인산화가 발효해삼(SJF) 및 발효흑삼(BGF)보다 높은 것이 관찰되었고 핵 내 NF-κB 발현이 MAPKs 결과와 유사하게 증가되는 것이 관찰되었으며, NF-κB 발현도 해삼복합소재(SJBG-F)가 발효해삼(SJF) 및 발효흑삼(BGF)보다 높은 것이 관찰되었다. 따라서 발효해삼(SJF), 발효흑삼(BGF) 및 해삼복합소재(SJBG-F)는 MAPKs의 인산화 및 NF-κB의 발현으로 인해 면역활성을 유도하며, 그 중 해삼복합소재(SJBG-F)가 가장 높은 면역활성을 유도하는 것을 확인할 수 있었다. Phosphorylation of ERK1/2 and p38 due to sea cucumber composite (SJBG-F) was observed to be higher than that of fermented sea cucumber (SJF) and fermented black ginseng (BGF), and NF-κB expression in the nucleus was observed to increase similarly to MAPKs results. and NF-κB expression was observed to be higher in sea cucumber composite (SJBG-F) than in fermented sea cucumber (SJF) and fermented black ginseng (BGF). Therefore, fermented sea cucumber (SJF), fermented black ginseng (BGF) and sea cucumber complex (SJBG-F) induce immune activity due to phosphorylation of MAPKs and expression of NF-κB, among which sea cucumber complex (SJBG-F) is It was confirmed that it induces the highest immune activity .

발효해삼(SJF), 발효흑삼(BGF) 및 해삼복합소재(SJBG-F) 모두 CD80, CD86, MHC class I과 II의 발현이 증가하는 것이 관찰되었으며, 이전 결과와 유사하게 해삼복합소재(SJBG-F)가 발효해삼(SJF) 및 발효흑삼(BGF)보다 높게 발현되는 것이 관찰되었다. 이러한 결과로 보아 해삼복합소재(SJBG-F)가 발효해삼(SJF) 및 발효흑삼(BGF)보다 세포 표면 활성 인자 발현이 높아서 면역활성이 높은 것을 확인할 수 있었다.Fermented sea cucumber (SJF), fermented black ginseng (BGF) and sea cucumber composite (SJBG-F) all showed increased expression of CD80, CD86, and MHC class I and II, and similarly to the previous results, sea cucumber composite (SJBG-F) F) was observed to be expressed higher than that of fermented sea cucumber (SJF) and fermented black ginseng (BGF). From these results, it was confirmed that the sea cucumber composite (SJBG-F) had higher cell surface activator expression than fermented sea cucumber (SJF) and fermented black ginseng (BGF), and thus had higher immune activity.

실시예 1. 발효해삼 추출물 및/또는 발효흑심 추출물은 유효성분으로 함유하는 면역력 증진 조성물 및 이를 이용한 제제Example 1. Immunity enhancing composition containing fermented sea cucumber extract and/or fermented black heart extract as an active ingredient and formulation using the same

상기 실험예 1 및 2에 따라 제조되는 발효해삼 추출물 및/또는 발효흑삼 추출물을 이용하여 면역력 증진 조성물 및 이를 이용한 제제를 실시할 수 있다. By using the fermented sea cucumber extract and/or the fermented black ginseng extract prepared according to Experimental Examples 1 and 2, an immunity enhancing composition and a formulation using the same can be carried out.

실험예 1 및 2를 통해 알 수 있듯이, 흑삼과 해삼을 발효시킴으로써 각 물질의 산성다당체가 증진되고, 흑삼은 특유의 진세노사이드가 증가되며, 발효흑삼 추출물과 발효해삼 추출물 각각이 모두 면역활성을 지니고 있기 때문이다. 또한, 발효해삼 추출물과 발효흑삼 추출물을 3:7 중량비 혼합한 혼합물 역시 면역활성을 지니고 있기 때문이다.As can be seen from Experimental Examples 1 and 2, by fermenting black ginseng and sea cucumber, the acidic polysaccharide of each material is enhanced, and the unique ginsenosides of black ginseng are increased, and both the fermented black ginseng extract and the fermented sea cucumber extract exhibited immune activity. because it has In addition, this is because the mixture of the fermented sea cucumber extract and the fermented black ginseng extract in a 3:7 weight ratio also has immune activity.

본 실시예에 따른 조성물에는 약제학적으로 허용가능한 첨가제 또는 식품학적으로 허용가능한 첨가제가 추가로 포함될 수 있다. 또한, 다양한 제형을 위한 제제가 추가로 포함되어 환, 태블릿, 산제, 주사제, 파우더 등의 형태로 실시될 수 있다. The composition according to this embodiment may further include a pharmaceutically acceptable additive or a food acceptable additive. In addition, formulations for various formulations may be additionally included and implemented in the form of pills, tablets, powders, injections, powders, and the like.

지금까지 본 발명에 대하여 바람직한 실시예를 중심으로 살펴보았다.So far, the present invention has been focused on preferred embodiments.

본 명세서에 기재된 실시예와 도면에 도시된 구성은 본 발명의 가장 바람직한 하나의 실시예에 관련된 것이고, 본 발명의 기술적 사상을 모두 대변하는 것은 아니므로, 이들을 대체할 수 있는 다양한 균등물과 변형된 예들이 있을 수 있음을 이해하여야 한다.The embodiments described in this specification and the configurations shown in the drawings relate to one most preferred embodiment of the present invention, and do not represent all of the technical spirit of the present invention, so various equivalents and modifications that can be substituted for them are It should be understood that there may be examples.

따라서 본 발명은 제시되는 실시예에 한정되지 않으며, 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자에 의하여 본 발명의 기술 사상과 아래에 기재될 특허청구범위에 기재된 기술사상의 균등한 범위 내에서 다양한 수정 및 변경이 가능한 실시예가 있을 수 있다.Therefore, the present invention is not limited to the presented embodiment, and within the equivalent scope of the technical spirit of the present invention and the technical spirit described in the claims to be described below by those of ordinary skill in the technical field to which the present invention belongs. There may be embodiments in which various modifications and changes are possible.

Claims (5)

발효해삼 추출물 또는 발효흑삼 추출물 중 1 종 이상을 유효성분으로 함유하는 면역력 증진 조성물.An immunity enhancing composition comprising at least one of fermented sea cucumber extract or fermented black ginseng extract as an active ingredient. 청구항 1에 있어서,
발효 균주는 백국균인 것을 특징으로 하는 면역력 증진 조성물.
The method according to claim 1,
The fermented strain is an immunity enhancing composition, characterized in that the white chrysanthemum.
청구항 1에 있어서,
발효해삼이 이용되는 경우, 발효해삼은 건조해삼에 대하여 백국균을 1% 첨가하여 60시간 발효한 것을 특징으로 하는 면역력 증진 조성물.
The method according to claim 1,
When fermented sea cucumber is used, the fermented sea cucumber is an immunity enhancing composition, characterized in that the dried sea cucumber is fermented for 60 hours by adding 1% of Baekkuk bacteria.
청구항 1 내지 3 중 어느 한 항에 있어서,
발효해삼 추출물 및 발효흑삼 추출물이 혼합될 경우,
발효해삼 추출물과 발효흑삼 추출물은 3:7 중량비로 혼합되는 것을 특징으로 하는 면역력 증진 조성물.
4. The method according to any one of claims 1 to 3,
When fermented sea cucumber extract and fermented black ginseng extract are mixed,
Immunity enhancement composition, characterized in that the fermented sea cucumber extract and the fermented black ginseng extract are mixed in a weight ratio of 3:7.
청구항 1에 있어서,
상기 조성물은,
활성산소종을 증가시키지 않고, 사이토카인(TNF-α, IL-6 , IL-1β) 분비능과 산화질소 분비능을 향상시키고, MAPKs의 인산화 및 NF-κB의 발현과 세포 표면 활성 인자 발현을 유도하는 것을 특징으로 하는, 면역력 증진 조성물.
The method according to claim 1,
The composition is
Without increasing reactive oxygen species, cytokine (TNF-α, IL-6, IL-1β) secretion and nitric oxide secretion, MAPKs phosphorylation, NF-κB expression, and cell surface activator expression induction Characterized in that, immunity enhancing composition.
KR1020210038564A 2021-03-25 2021-03-25 A composition comprising fermented Stichopus japonicus extract and fermented Black ginseng extract for improvement of immunity KR102643524B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020210038564A KR102643524B1 (en) 2021-03-25 2021-03-25 A composition comprising fermented Stichopus japonicus extract and fermented Black ginseng extract for improvement of immunity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020210038564A KR102643524B1 (en) 2021-03-25 2021-03-25 A composition comprising fermented Stichopus japonicus extract and fermented Black ginseng extract for improvement of immunity

Publications (2)

Publication Number Publication Date
KR20220133454A true KR20220133454A (en) 2022-10-05
KR102643524B1 KR102643524B1 (en) 2024-04-02

Family

ID=83596612

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020210038564A KR102643524B1 (en) 2021-03-25 2021-03-25 A composition comprising fermented Stichopus japonicus extract and fermented Black ginseng extract for improvement of immunity

Country Status (1)

Country Link
KR (1) KR102643524B1 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130081009A (en) 2012-01-06 2013-07-16 송흥규 Preparation method of red ginseng pill with dried sea cucumber and red ginseng pill with dried sea cucumber preparated by the same
KR101670810B1 (en) * 2015-11-27 2016-10-31 재단법인 금산국제인삼약초연구소 A method for manufacturing a fermented black ginseng containing the increased amount of minor ginsenosides, and the fermented black ginseng thereof
KR101659974B1 (en) * 2016-01-21 2016-11-16 손미례 A method for manufacturing the extract of a fermented black ginseng with anti-aging activity, and the extract of the fermented black ginseng
KR101708167B1 (en) 2015-10-05 2017-02-20 한국해양바이오클러스터 주식회사 Food compositions containing hydrolysis raw materials of red ginseng and sea cucumber and methods for producing the same
KR101712565B1 (en) 2015-01-29 2017-03-06 피엘수산주식회사 Preparation Method of Steamed Dried Sea Cucumber and Manufacturing Method of a Healthy Products Thereof
KR101767837B1 (en) * 2016-06-14 2017-08-14 남찬열 Method for producing mixture extract of sea cucumber and sea mustard with enhanced immunity activity

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130081009A (en) 2012-01-06 2013-07-16 송흥규 Preparation method of red ginseng pill with dried sea cucumber and red ginseng pill with dried sea cucumber preparated by the same
KR101712565B1 (en) 2015-01-29 2017-03-06 피엘수산주식회사 Preparation Method of Steamed Dried Sea Cucumber and Manufacturing Method of a Healthy Products Thereof
KR101708167B1 (en) 2015-10-05 2017-02-20 한국해양바이오클러스터 주식회사 Food compositions containing hydrolysis raw materials of red ginseng and sea cucumber and methods for producing the same
KR101670810B1 (en) * 2015-11-27 2016-10-31 재단법인 금산국제인삼약초연구소 A method for manufacturing a fermented black ginseng containing the increased amount of minor ginsenosides, and the fermented black ginseng thereof
KR101659974B1 (en) * 2016-01-21 2016-11-16 손미례 A method for manufacturing the extract of a fermented black ginseng with anti-aging activity, and the extract of the fermented black ginseng
KR101767837B1 (en) * 2016-06-14 2017-08-14 남찬열 Method for producing mixture extract of sea cucumber and sea mustard with enhanced immunity activity

Also Published As

Publication number Publication date
KR102643524B1 (en) 2024-04-02

Similar Documents

Publication Publication Date Title
JP2014087364A (en) Edible apios blossom, food raw material, substance having blood glucose level elevation-inhibiting effect, blood glucose level elevation inhibiting-substance, and method for using the apios blossom
Zhu et al. Preparation and toxicological evaluation of methyl pyranoanthocyanin
Kimira et al. Citrus limonoid nomilin inhibits osteoclastogenesis in vitro by suppression of NFATc1 and MAPK signaling pathways
KR100803998B1 (en) Fermented extract of Citrus Sunkii Hort, Method for processing thereof, and the healthy and funtional foods
JP2011026207A (en) Composition for oral administration or for external use preparing polyphenol and application thereof
Cao et al. Lectin purified from Musca domestica pupa up-regulates NO and iNOS production via TLR4/NF-κB signaling pathway in macrophages
KR20220133454A (en) A composition comprising fermented Stichopus japonicus extract and fermented Black ginseng extract for improvement of immunity
KR20220133456A (en) A method of manufacturing a composition comprising fermented Stichopus japonicus extract and fermented Black ginseng extract
WO2015152682A1 (en) Composition for preventing, ameliorating and treating bone diseases, comprising extract of longanae arillus as active ingredient
Yao et al. Structural characterization and antitumor and mitogenic activity of a lectin from the gill of bighead carp (Aristichthys nobilis)
CN110832317B (en) Method for identifying tea quality
CN109010384A (en) Inonotus obliquus extract and preparation method thereof, pharmaceutical composition and purposes
CN115025139A (en) Application of quinoa polyphenol in regulating glycolipid metabolism of liver cells and inhibiting oxidative stress
JP6673558B2 (en) Method for Preparing Cell Extract Component or Composition Having Cell Killing Activity
KR20130134730A (en) Composition for improving liver function containing fermented liquor of hovenia dulcis thunb extract as effective component
KR101545495B1 (en) Pharmaceutical Composition and Functional Food for Preventing or Treating Neurodegenerative Disease by Saururus Chinesis Extracts and Quercetin as Effective Component, and Extracting Method of Saururus Chinesis Extracts
KR20110087397A (en) A composition comprising isodihydroauroglaucin as an active ingredient for treating and preventing cancer disease
EP3689345A1 (en) Composition for prevention, alleviation, and/or treatment of heat stroke
Nobushi et al. Inhibitory effects of the edible mushroom Flammulina velutipes on lipid accumulation in 3T3-L1 cells
CN104254326A (en) 4-oxo-2-pentenoic acid and cardiovascular health
TWI719740B (en) Method for preparing plant fermentation product, and uses of the fermentation product and its active ingredients
KR101387966B1 (en) A Composition comprising cytochalasin b as an active ingredient for treating and preventing cancer disease
KR102141862B1 (en) Increasing method of cordycepin of Cordyceps millitaris and bioactive compounds of strawberry and Composition for preventing or treating obesity comprising fermented extracts
Masalu et al. Induction of early apoptosis and reactive oxygen species (ROS) production by Tanzanian basidiomycete (Cantharellus miomboensis)
WO2016073843A2 (en) Enhanced expression of mtor and inhibited expression of myostatin in skeletal muscle cells

Legal Events

Date Code Title Description
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
N231 Notification of change of applicant
GRNT Written decision to grant